Osteo-Medic s.c. Artur Racewicz, Jerzy Supronik

The medical center is at the forefront of psoriatic arthritis research, focusing on innovative treatments to improve patient outcomes. The center's work in this area is driven by a commitment to understanding the complex mechanisms of the disease and developing targeted therapies.

• Comparative Efficacy Studies
• Safety and Tolerability Assessments
• Innovative Therapeutic Approaches

Through rigorous clinical trials, the center evaluates the efficacy of novel treatments such as bimekizumab, providing valuable insights into their potential benefits over existing therapies like risankizumab. This research not only enhances the understanding of treatment dynamics but also contributes to the development of more effective management strategies for patients with active psoriatic arthritis.